The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MOR202 with low-dose dexamethasone (Dex) and in combination with pomalidomide/dex and lenalidomide/dex in relapsed or refractory multiple myeloma (RRMM): Interim analysis of a phase I/IIa dose-escalation study.
 
Marc Raab
Honoraria - Amgen; Celgene; MorphoSys; Novartis
Consulting or Advisory Role - Amgen; Celgene; MorphoSys; Novartis
Research Funding - MorphoSys; Novartis
Travel, Accommodations, Expenses - Amgen; Celgene; MorphoSys; Novartis
 
Manik Chatterjee
No Relationships to Disclose
 
Hartmut Goldschmidt
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Millennium; MorphoSys; Novartis; Takeda
Consulting or Advisory Role - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Millennium (Inst); MorphoSys (Inst); Novartis (Inst); Takeda (Inst)
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Janssen-Cilag; Millennium; Novartis; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Janssen-Cilag (Inst); Johnson & Johnson (Inst); Mundipharma (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb/Sanofi; celgene; Janssen; Janssen-Cilag; Millennium; Novartis; Takeda
 
Hermine Agis
No Relationships to Disclose
 
Igor W. Blau
Research Funding - Celgene (Inst); Janssen-Cilag (Inst)
 
Hermann Einsele
Honoraria - Celgene; Janssen
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis
Speakers' Bureau - Amgen; Celgene; Janssen; Novartis
Research Funding - Celgene; Janssen
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Novartis
 
Monika Martha Engelhardt
No Relationships to Disclose
 
Barbara Ferstl
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - PharmaMar
 
Martin Gramatzki
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MorphoSys; Novartis
Speakers' Bureau - Amgen; Celgene
 
Christoph Röllig
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Roche; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen; Novartis; Takeda
Research Funding - Bayer
Travel, Accommodations, Expenses - Amgen; Celgene; Gilead Sciences; Janssen
 
Katja C. Weisel
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Onyx; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Onyx; Takeda
Research Funding - Amgen (Inst); Celgene (Inst); Janssen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda
 
Tiantom Jarutat
Employment - MorphoSys
 
Dominika Weinelt
Employment - MorphoSys
 
Mark Winderlich
Employment - MorphoSys
Patents, Royalties, Other Intellectual Property - MorphoSys
 
Rainer Boxhammer
Employment - MorphoSys
Stock and Other Ownership Interests - MorphoSys
Patents, Royalties, Other Intellectual Property - MorphoSys
 
Christian Peschel
Honoraria - Amgen; Bristol-Myers Squibb; MorphoSys
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb